Home › Funds › SUMMER ROAD LLC › OCUL

SUMMER ROAD LLC position in OCUL

OCULAR THERAPEUTIX INC · Health Care

SUMMER ROAD LLC reported holding 12,463,296 shares of OCUL (OCULAR THERAPEUTIX INC) in its Q3 2026 13F filing — a position valued at US$95.6M, representing 70.72% of its reported portfolio and ranking #1 among its reported holdings. SUMMER ROAD LLC has disclosed OCUL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)12.46M sh
Reported value held$95.59M
Portfolio Weight70.72%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SUMMER ROAD LLC's OCUL position evolved

SUMMER ROAD LLC first disclosed a stake in OCUL in Q3 2023 at 6,122,089 shares (US$19.2M). The position peaked in Q3 2025 at 12,579,657 shares, worth US$147.1M. Across 13 filings, SUMMER ROAD LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 12,463,296 shares valued at US$95.6M — an increase of 255,000 shares quarter over quarter.. Notable position changes include a 25% increase in Q4 2023 (shares rose 104% over the following quarter), a 87% increase in Q1 2024 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.12M $19.22M New
Q4 2023 7.66M $34.17M Add
Q1 2024 14.36M $130.68M Add
Q2 2024 14.89M $101.82M Add
Q3 2024 14.40M $125.26M Reduce
Q4 2024 13.87M $118.45M Reduce
Q1 2025 13.88M $101.73M Hold
Q2 2025 13.89M $128.88M Hold
Q3 2025 12.58M $147.05M Reduce
Q4 2025 11.11M $134.86M Reduce
Q1 2026 11.88M $100.62M Add
Q2 2026 12.21M $119.89M Add
Q3 2026 12.46M $95.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCUL and 13F data

OCUL (OCULAR THERAPEUTIX INC) is a Health Care company. 37 other funds we track also report a position in OCUL — the largest reported positions include Deep Track Capital, LP (US$193.3M), Avoro Capital Advisors LLC (US$123.1M), Venrock Adviser, LLC (US$101.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCUL

All OCUL fund holders →

FAQ

How long has SUMMER ROAD LLC held OCUL?

SUMMER ROAD LLC has disclosed OCUL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SUMMER ROAD LLC's current position in OCUL?

As of Q3 2026, SUMMER ROAD LLC holds 12.46M shares of OCUL (OCULAR THERAPEUTIX INC), valued at $95.59M, representing 70.72% of its reported portfolio and ranking #1.

Has SUMMER ROAD LLC been buying or selling OCUL?

In the latest 13F filing (Q3 2026), SUMMER ROAD LLC increased its position in OCUL. The position peaked in Q3 2025 at 12.58M shares.

Which other funds hold OCUL?

Other major institutional holders of OCUL include Deep Track Capital, LP, Avoro Capital Advisors LLC, Venrock Adviser, LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.